
Spectrum Pharmaceuticals Investor Relations Material
Latest events

Q4 2022
Spectrum Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Spectrum Pharmaceuticals Inc
Access all reports
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, engages in developing and commercializing oncology and hematology drug products. It operates through the following segments: North American Sales, International Sales, and Research and Development. The company's product candidates include FUSILEV , ZEVALIN, VALSTAR, GAMMATOPHOS, KYTRIL, SUTENT, and VORAXAZE. It offers FUSILEV (levoleucovorin) oral granules, ZEVALIN (ibritumomab tiuxetan) for injection for the treatment of patients with indolent non-Hodgkin's lymphoma monitored by x-ray prior to treatment and during treatment cycle number one; cancer of the ovary or fallopian tube. Spectrum Pharmaceuticals, Inc. is based in Henderson, Nevada.
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
SPPI
Country
🇺🇸 United States